CABA US Equity
Cabaletta Bio, Inc.Health Care · Biological Products, (No Diagnostic Substances) · CIK 1759138 · FY ends Dec 31$3.10
+0.19 (+6.53%)
USD · as of 2026-08-19 · marketstack
Short interest· FINRA consolidated · settlement 2026-07-31
6 settlement cycles| Shares short | 40.8M |
| % of shares out | 24.1% |
| Days to cover | 18.4 |
| Δ vs 2026-07-15 | -0.6% |
bars = shares short · line = days to cover (own scale)
| Settlement | Shares short | Δ vs prior | Avg daily volume | Days to cover |
|---|
| 2026-07-31 | 40,777,017 | -0.6% | 2,210,652 | 18.4 |
| 2026-07-15 | 41,009,848 | +20.4% | 6,092,298 | 6.7 |
| 2026-06-30 | 34,060,216 | +29.8% | 7,861,382 | 4.3 |
| 2026-06-15 | 26,240,080 | +14.4% | 3,479,108 | 7.5 |
| 2026-05-29 | 22,943,123 | +0.4% | 3,020,332 | 7.6 |
| 2026-05-15 | 22,843,626 | +10.7% | 7,020,652 | 3.3 |
FINRA Rule 4560 · twice monthly, published ~a week later.
Output of a disclosed model — assumptions may be wrong. Research, not investment advice. See the Disclaimer.
